C erebral microbleeds (CMBs) are small areas of hemosiderin deposition, detected on brain MRI, which are found in ≈23% of the cognitively normal population over age 60 years. 1 CMBs predict future risk of hemorrhagic 2 and ischemic stroke. They are associated with increased cardiovascular mortality. 4, 5 CMB location (deep versus strictly lobar) may be indicative of underlying pathology with deep CMBs being more associated with hypertensive vascular disease and lobar CMBs being more associated with cerebral amyloid angiopathy. 6 In patients with Alzheimer disease (AD) or vascular dementia, those with lobar only CMBs have a higher amyloid burden than those with mixed lobar and deep CMBs or deep only CMBs. 7 The frequency and neuroimaging correlates of CMBs in a large biracial, nondemented population require further investigation.
Methods

Participants
ARIC is a prospective epidemiological study that began with baseline examination of cardiovascular risk factors in men and women aged 45 to 64 years between 1987 and 1989 who represented 4 US communities (Washington County, MD; Forsyth County, NC; Jackson, MS; and suburban Minneapolis, MN). Between June 2011 and August 2013, ARIC conducted a fifth examination. 8 Of 10 749 original ARIC cohort members alive at the start of the fifth examination, 6538 (aged 66-90 years) took part. A subset of fifth visit participants were considered for MRI scans, including (1) All individuals with cognitive impairment, defined by low MiniMental State Examination scores (<19 for blacks and <21 for whites) or a low age-, race-, and education-adjusted z score on at least 1 of 5 cognitive domains (failure on the clock reading test for visuospatial domain or z scores below −1.5 for memory, language, executive function, or attention domains) accompanied by cognitive decline between visits (below the 10th percentile for change in the delayed word recall, digit symbol substitution, or word fluency test or below the 20th percentile for change on ≥2 of these tests); (2) all participants with a prior brain MRI; and (3) an ageand field center-stratified random sample of cognitively normal individuals. From this subset, 1928 participants were free of MRI contraindications, gave informed consent, and completed the MRI scan. We excluded participants from this analysis because of poor scan quality, missing covariate values, limits on data use, dementia (assessment and adjudication detailed in Ref 8 ), or unknown cognitive status, yielding an analysis sample size of 1677 participants. See Figure 1 for details. Institutional Review Boards of each ARIC center approved the protocol, and all participants provided written informed consent.
Covariate Definitions
Education was self-reported at the first ARIC visit (1987) (1988) (1989) and categorized as less than high school, high school, General Educational Development tests, or vocational school, or some college. Unless otherwise specified, covariates were defined at visit 5. Blood pressure was categorized as normal (systolic blood pressure <120 mm Hg, diastolic blood pressure <80 mm Hg, and no antihypertensive use), pre-hypertension (120≤ systolic blood pressure <140 mm Hg or 80≤ diastolic blood pressure <90 mm Hg in absence of antihypertensive use), or hypertension (systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or antihypertensive use). Diabetes mellitus was defined by medication use, a fasting glucose ≥126 mg/dL, or a nonfasting glucose ≥200 mg/ dL. Smoking status was self-reported; never smoked was defined as anyone reporting never smoking >100 cigarettes. Ever smokers included current and former smokers across multiple visits. Race site indicators for Jackson blacks, suburban Minneapolis whites, and Washington County whites were used, leveraging Forsyth County whites as the reference. Although not used in the regression models because of a lack of statistical significance (P≥0.20 for all global and individual Wald tests), dyslipidemia was defined by cholesterol-lowering medication use, a fasting total cholesterol ≥240 mg/dL, high-density lipoprotein <40 mg/dL (men) or <50 mg/ dL (women), or low-density lipoprotein ≥160 mg/dL.
Predictors
Apolipoprotein E
The APOE genotypes were determined via TaqMan assays and the ABI 7700 Sequence Detection System (Applied Biosystems, Foster City, CA). Seven participants did not consent to DNA use and were excluded from all analyses involving APOE. 
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Imaging MRI scans were performed at each site on 3-Tesla Siemens scanners. Standardized 3D Magnetization Prepared Rapid Acquisition Gradient-Echo and fluid-attenuated inversion recovery (FLAIR) developed for the multi-center Alzheimer's Disease Neuroimaging Initiative were used for imaging. 9, 10 The Magnetization Prepared Rapid Acquisition Gradient-Echo image was used to assess gray matter volumes, and the FLAIR image was used to assess infarcts and quantification of WMH.
FLAIR Image Assessment: Brain infarcts were assessed visually on FLAIR images by a trained image analyst and confirmed by a radiologist (KK or CRJ) blinded to all clinical information. Lacunar infarcts, small subcortical cavity 3 to 15 mm in diameter with surrounding hyperintensity on FLAIR sequence, were defined according to consensuses recommendations using a cutpoint of 15 mm.
11
Hyperintensities associated with infarcts are marked and were not included in the total WMH volume because of distinct pathophysiologic differences between the 2 lesions.
12 WMH volumes were measured using a semiautomated segmentation algorithm as previously described. 13 Structural MRI Analysis: Total intracranial volume estimated from Freesurfer was used.
14 Using the Freesurfer atlas, 15 we prespecified 2 regions of interest (ROIs) based on relevance to AD or cerebrovascular disease: (1) AD signature ROI: hippocampus, parahippocampal, entorhinal, inferior parietal lobule, precuneus, and cuneus; and (2) frontal ROI: mean cortical volume of regions in the frontal lobe from both right and left hemispheres: rostral/caudal anterior cingulate, rostral/caudal midfrontal, lateral orbital frontal, medial orbital frontal, paracentral, pars opercularis, pars orbitalis, pars triangularis, precentral, superior frontal, and frontal pole.
Microbleed Outcomes
CMBs were graded using a T2* gradient echo (repetition time/echo time=200/20 ms; flip angle=12°; field of view=20 cm; in-plane matrix=256×224; phase field of view=1.00; slice thickness=3.3 mm; time is 5 minutes). CMBs were defined as homogenous hypointense lesions ≤10 mm in diameter in the gray or white matter on T2* gradient echo images as previously described. All CMBs were identified by trained image analysts and secondarily confirmed by a radiologist (KK or CJ) and were categorized as definite or possible with only definite CMBs being used in the analysis. The interrater agreement between the 2 raters on definite versus not-definite CMB was 85% (κ=68%). 16 Composite maps of CMBs locations across subjects were built by transforming T2* gradient echo image locations into the T1 image space and applying the discrete cosine transformation to the template space derived from Statistical Parametric Mapping. 16 CMBs were categorized as lobar (cortical gray and subcortical or periventricular white matter), deep (deep gray matter: basal ganglia and thalamus; and the white matter of the corpus callosum, internal, external, and extreme capsule), and infratentorial (brain stem and cerebellum). For analysis, definite CMBs were divided into strictly lobar microbleeds (participants with ≥1 microbleeds limited to a lobar region) and deep/mixed microbleeds (participants with ≥1 microbleeds in a deep or infratentorial region with or without lobar microbleeds) because lobar CMBs in individuals with deep CMBs are similar to those with deep alone.
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Statistical Methods
The WMH volumes were right-skewed and required a logarithmic base 2 transformation. Lacunar and total infarct frequencies were recoded to collapse values ≥3 while the nonlacunar infarct frequencies were recoded to collapse values ≥2. The distribution of the infarct frequencies and the relationship between infarct frequencies and CMB risks determined these thresholds. Because of the sampling selection scheme, participants who completed MRI scans were not representative of all participants who completed the fifth visit. Therefore, all statistical tests and models were weighted back to the latter. Weights, equaling the product of the inverse sampling fractions and the inverse probability of completing the examination, were incorporated into survey options in Stata.
Poisson and multinomial logistic regression models estimated the effect of each predictor on CMB presence (yes/no) and location, respectively, while adjusting for age, sex, education, hypertension status, smoking status, diabetes mellitus, race site, and estimated intracranial volume (for models including a brain volume predictor). We included interaction terms to gauge whether total intracranial volume estimated or predictor effects were modified by age, sex, or race (captured by the Jackson race site indicator because all included blacks hailed from that field center); an interaction was deemed significant at the 0.05 level if its global Wald test was less than the Bonferronicorrected threshold (corrected for the total number of experimentwide interaction tests conducted). Any interaction included in the Poisson model of CMB presence was included in the multinomial logistic model of CMB location and vice versa. We present the effect estimates and 95% confidence intervals for all predictors included in the Poisson and multinomial logistic models but do not perform further adjustments for multiple testing; the associations between many of the predictors and microbleed presence/location were not expected to represent independent statistical tests (particularly for lacunar, nonlacunar, and total infarct frequencies and brain volumes with overlapping regions).
Last, we fit Poisson and multinomial logistic models of all neurological predictors simultaneously while adjusting for covariates; we used a forward selection method, adding neurological predictors in order of significance until the remaining predictors had no appreciable impact (global Wald test P≥0.20 and individual relative risk and relative risk ratio P≥0.20).
Results
The descriptive statistics for the analyzed and excluded participants from the fifth visit are shown in Table 1 . White participants from suburban Minneapolis were under-represented in the analyzed data (24% versus 31% of excluded participants), whereas black participants from Jackson were overrepresented (26% and 20% of the analyzed and excluded participants, respectively). The analysis sample was enriched for mild cognitive impairment (36% compared with 16% in the excluded sample) but contained no demented individuals. Additional cognitive information on the full, analyzed, and excluded samples is detailed in Table I in the online-only Data Supplement.
Among the 1677 nondemented participants analyzed, 24% had CMBs, 16% had strictly lobar CMBs, and 8% had deep or mixed CMBs. The CMB prevalence after accounting for oversampling of cognitive impairment and MRI refusal was similar (22%), with weighted prevalences of 14% and 7% for strictly lobar and deep/mixed CMBs, respectively (see Table  II in the online-only Data Supplement for weighted summary statistics). The observed prevalences of CMBs in blacks and whites were 27% (9% deep/mixed+18% strictly lobar) and 23% (8% deep/mixed+15% strictly lobar), respectively, while the weighted prevalences were 26% (8% deep/mixed+18% strictly lobar) and 21% (7% deep/mixed+14% strictly lobar).
Participants with CMBs, regardless of location, had higher prevalence rates of mild cognitive impairment with and without weighting. Summary statistics revealed differences in covariates, particularly sex and hypertension status, across CMB locations. Men were overrepresented in the strictly lobar group. The strictly lobar and deep/mixed groups had the highest proportion of pre-hypertensives and hypertensives, respectively. Simultaneously, including all covariates in (5) 76 (5) 76 (5) 77 (5) 77 (5) Education, n (%)
Less than high school 769 (16) 218 (13) 156 (12) 20 (15) 
Forsyth County whites 946 (20) 390 (23) 288 (23) 42 (31) 60 (23) Jackson blacks 974 (20) 441 (26) 322 (25) 38 ( (11) 150 (12) 12 (9) 24 (9) Pre-hypertensive 684 (14) 241 (14) 184 (14) 15 (11) (2) 18 (1) 6 (5) 14 (6) The statistics are the observed frequencies and means. AD indicates Alzheimer disease; APOE, apolipoprotein E; CMB, cerebral microbleeds; and GED, General Educational Development tests.
*The frontal volume exhibited significant interactions with sex; thus sex-specific summary statistics are presented along with the overall (combined sex) values. The Poisson (CMB presence) and multinomial logistic (CMB location) regression models included adjustments for age, sex, education, hypertension, smoking status, diabetes mellitus, race site (used Forsyth as the reference), and estimated intracranial volume. The number of lacunar infarcts and the total number of infarcts were modeled with a single variable that took values 0, 1, 2, or 3 (for ≥3) infarcts. The number of nonlacunar infarcts was modeled with a single variable that took values 0, 1, or 2 (for ≥2) infarcts. Models incorporated weights accounting for the MRI sampling and completion probabilities. AD indicates Alzheimer disease; APOE, apolipopretein E; CI, confidence interval; CMB, cerebral microbleed; RR, relative risk; RRR, relative risk ratio; and WMH, white matter hyperintensity.
Minneapolis and Washington County which recruited whites) were associated with a lower risk of deep/mixed CMBs compared with the Forsyth County site.
Neuroimaging/APOE
Summary statistics showed that the WMH volume distribution and infarct (lacunar, nonlacunar, and total) frequencies differed by CMB location (see Table 1 ). Larger WMH volume, greater infarct (lacunar, nonlacunar, and total) frequencies, APOE ε4 homozygosity, smaller AD signature region volume, and smaller total gray volume were associated with an increased prevalence of CMB via single-predictor Poisson regression models adjusted for covariates (see Table 2 ; singlepredictor models without covariate adjustments are shown in Table IV in the online-only Data Supplement). The effect of frontal volume on CMB presence differed by sex (interaction P=0.0003); greater frontal volumes were associated with lower risk of CMBs in females and higher risk in males (although the male confidence interval contained one). No other predictors had significant age, sex, or race interactions in the CMB presence or location models. Figures I and II in the online-only Data Supplement display the probabilities of CMB presence across the spectrum of predictor values; the predicted probabilities account for the covariates by averaging across the values in our sample (weighted to the fifth visit participants). Although the estimated relative risks per 1-cm 3 change in frontal volume seem similar in the 2 sexes, the frontal volume by sex interaction is evident in Figure I in the online-only Data Supplement.
To assess whether these associations were location dependent, we fit multinomial logistic regression models for each neurological predictor adjusted for all covariates. Table 2 shows the relative risk ratios from these models while Figure 2 and Figure III in the online-only Data Supplement depict the predictive probabilities for the strictly lobar, deep/mixed, and total CMB outcomes. Smaller frontal volume in females, smaller total gray volume, larger WMH volume, and greater total infarct frequencies were associated with increased probabilities of both strictly lobar and deep/mixed CMBs. The impact of the interaction between frontal volume and sex on each microbleed location is depicted in the last 2 graphs in Figure III in the online-only Data Supplement.
There were predictors with location-specific effects. Smaller volumes in the AD signature regions (see Figure III in the online-only Data Supplement) and APOE ε4 homozygosity (see Figure 2) were associated with increased probabilities of strictly lobar CMBs; although the relative risk ratios of these 
Stroke
November 2017
predictors were similar in the strictly lobar and deep/mixed group, the confidence intervals of the latter contained one and the probability plots indicated negligible effects. Higher lacunar and nonlacunar infarct frequencies were associated with increased probabilities of deep/mixed CMBs. In the model containing all significant predictors together (see Table 3 ), the total gray volume, lacunar infarcts, and nonlacunar infarcts were dropped. The effect estimates of the remaining predictors were consistent with the single-predictor models. Smaller volumes in the AD-related regions were associated with strictly lobar CMBs after accounting for APOE ε4 status.
Discussion
In a biracial group of nondemented elderly individuals, the presence of CMBs was associated with older age, male sex, hypertension, and cognitive impairment. CMBs were not associated with diabetes mellitus, dyslipidemia, or history of smoking. Greater WMH, total infarcts, lacunar infarcts, nonlacunar infarcts, APOE ε4 allele homozygosity, lower total gray matter volume, and AD signature region volume were associated with CMBs; frontal volume was associated with reduced CMB presence in women but not men. The imaging associations differed by CMB location implying distinct pathophysiology as we hypothesized. Lacunar infarcts were associated with deep CMBs while lower volume in AD signature regions was associated with strictly lobar CMBs. These findings support prior observations that deep CMBs are more associated with hypertensive small-vessel pathologies and strictly lobar CMBs with AD pathologies. 7 In fact, the mean WMH was greater in those with deep CMBs compared with strictly lobar CMBs, and APOE ε4 homozygosity was associated with strictly lobar CMBs but not deep CMBs.
Age and hypertension are consistent risk factors for CMBs across population-based studies. [17] [18] [19] Prior studies in predominantly European or European-American populations reported similar frequency. 18, 19 In the ARIC study, no significant difference in risk of CMB presence or location were detected by race. Two prior racially and ethnically diverse studies on CMBs revealed no difference in CMB frequency between black, white, and Hispanic individuals. 20, 21 Despite the association of CMBs with imaging markers of small-vessel disease, diabetes mellitus was not associated with CMBs in the present study or in the Framingham or Rotterdam studies.
17, 18 Similarly, in a prior ARIC study, diabetes mellitus was associated with infarcts but not WMH, 22 highlighting that small-vessel pathologies have overlapping but distinct mechanisms.
Male sex was associated with CMBs similar to the Framingham study 18 and AGES Reykjavik studies (Age, Gene/Environment Susceptibility-Reykjavik Study) 23 but differed from the Rotterdam Scan study, where no sex difference was detected. 19 The increased frequency of CMBs in men is interesting because WMH, also considered small-vessel pathology and associated with CMBs, is greater in both deep and periventricular regions in women compared with men. 24, 25 Although WMH is associated with CMBs, there is a difference in the sex distribution with CMBs being more common in men and WMH more severe in women. Understanding these sex differences between types of small-vessel pathologies may provide insights into future prevention studies. In a prior ARIC publication, WMH volume was associated with lower frontal ROI volume. 26 Therefore, it is not surprising that CMBs are associated with lower frontal ROI volume in women, who tend to have more WMH than men.
In the Rotterdam and the recent Framingham studies, the presence of an APOE ε4 allele (ie, homozygotes or heterozygotes) was associated with strictly lobar CMBs. [17] [18] [19] In contrast, in the present study and the AGES Reykjavik study, 23 APOE ε4 homozygosity was associated with CMBs while heterozygosity was not. In an autopsy series comparing CMBs identified in the hospital versus the population-based Framingham cohort, lobar CMBs were only associated with significant cerebral amyloid angiopathy in the hospital-based cohort. 27 Therefore, additional studies in population-based samples, including amyloid positron emission tomography and autopsies, are necessary to better understand the mechanisms of lobar CMBs.
In addition to hypertension, lacunar strokes and WMH volume were associated with deep CMBs. Similarly, in a cohort of dementia patients with Alzheimer dementia or subcortical vascular cognitive impairment, the number of lacunar strokes was associated with having a deep CMB. 7 Left ventricular hypertrophy 28 was associated with CMBs, supporting the notion that deep CMBs represent a manifestation of hypertensive small-vessel disease.
In the current study, lobar CMBs were associated with atrophy in AD signature regions but not with lacunar stroke. Because AD commonly coexists with cerebral amyloid angiopathy pathology, 29 this finding may reflect this strong association. The association between AD signature atrophy and lobar CMBs was not explained by the association of APOE ε4 and CMBs. In a model adjusting for APOE ε4 status, AD signature atrophy remained associated with lobar CMBs.
This study has several limitations. Although participants with dementia were excluded from the current analysis, the participants selected in this study were not a random sample of all surviving ARIC participants because those selected for imaging included persons who had been in the prior ARIC MRI study or who had low cognitive scores. Although our objective was to characterize the nondemented population, the exclusion of participants with dementia may lead to an underestimation of CMB frequency and weaken the association seen between AD signature region atrophy and CMBs. There were a greater number of participants with strictly lobar than deep/mixed CMBs; thus, the failure to identify significant AD signature region volume or APOE ε4 homozygosity associations could be because of insufficient power in the latter rather than differences in pathology. However, the deep/mixed CMB group could be more heterogeneous in pathogenesis because of the individuals with both deep and lobar CMBs; this may mask differences in AD pathology between the groups. All black participants included in this investigation were from the Jackson field center, making it impossible to distinguish the effect of race from the effect of the field center, particularly in tests of interactions. Only 39 blacks from the Forsyth County, suburban Minneapolis, and Washington County field centers were nondemented, gave consent, and had all necessary information (MRI outcomes and covariates), limiting their use in analyses. Last, we did not have sufficient numbers of microbleeds to perform race-stratified analyses while adjusting for covariates. Only 38 black participants had deep or mixed microbleeds and 81 had strictly lobar microbleeds. Although we tested the interaction between the Jackson site and each of the predictors, race-stratified analyses may be particularly important for predictors (such as the APOE ε4 allele) which differ in frequency between whites and blacks.
Conclusions
In a biracial study of nondemented participants, the frequency of CMBs remained substantial. AD signature region atrophy and APOE ε4 homozygosity were associated with lobar CMBs while lacunar infarcts were associated with deep CMBs.
